<DOC>
	<DOCNO>NCT00001702</DOCNO>
	<brief_summary>Innate immunity play important role fungal recognition initiation fungicidal activity . We hypothesize subtle difference different molecule innate immunity may contribute either predisposition clinical course infection Blastomycosis dermatitidis . To test hypothesis , propose analyze allelic frequency 15 different gene ( mannose binding lectin , Fc-gamma receptor IIa IIb , Fc-gamma receptor IIIa IIIb , myeloperoxidase , tumor necrosis factor-alpha -beta , interleukin 1A 1B , interleukin-1 receptor antagonist , interleukin-10 , NRAMP-1 , chitotriosidase , chemokine receptor 5 ) intragenic polymorphic form compare data incidence severity Blastomycosis dermatitidis infection . With study hope identify group molecule innate immunity influence risk severity invasive Blastomycosis dermatitidis infection .</brief_summary>
	<brief_title>Evaluation Association Polymorphisms Innate Immune System With Risk Blastomycosis Dermatitidis Infection Patients Not Infected With HIV Complications Associated With Blastomycosis Dermatitidis Infection</brief_title>
	<detailed_description>Innate immunity play important role fungal recognition initiation fungicidal activity . We hypothesize subtle difference different molecule innate immunity may contribute either predisposition clinical course infection Blastomycosis Dermatitidis . To test hypothesis , propose analyze allelic frequency 15 different gene ( mannose binding lectin , Fc-gamma receptor Ila IIb , Fc-gamma receptor IIIa IIIb , myeloperoxidase , tumor necrosis factor-alpha -beta , interleukin 1A 1B , interleukin-1 receptor antagonist , interleukin-10 , NRAMP-1 , chitotriosidase , chemokine receptor 5 ) intragenic polymorphic form compare data incidence severity Blastomycosis Dermatitidis infection . With study hope identify group molecule innate immunity influence risk severity invasive Blastomycosis Dermatitidis infection .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Blastomycosis</mesh_term>
	<criteria>INCLUSION CRITERIA : Patients database confirm diagnosis Blastomycosis dermatitides infection combination isolation yeast form diagnostic microbiology laboratory and/or elevate cryptococcal antigen titer ( commercially available ) . Only patient diagnose treat United States Canada include analysis . Only patient coinfected HIV include study . Patient sample collect clinical data evaluate signed consent obtain .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 6, 2009</verification_date>
	<keyword>Genetic</keyword>
	<keyword>Variant Alleles</keyword>
	<keyword>Risk Factor</keyword>
	<keyword>Cancer</keyword>
	<keyword>Transplantation</keyword>
</DOC>